Meda Pharma introduces 5ml nasal spray Rhinolast Allergy
Meda Pharmaceuticals has introduced 5ml nasal spray Rhinolast Allergy as an over-the-counter therapy to help children from the age of five tackle their hayfever misery.
Rhinolast Allergy is a non-steroid treatment and is suitable for children from as young as five years old.
Meda Pharma claims Rhinolast Allergy targets the symptoms of red, swollen and itchy eyes, runny nose and sneezing within minutes and can be used by children for up to four weeks without a doctor's intervention.
It contains the active ingredient azelastine which is more than just a simple anti-histamine.
It is the only anti-histamine with a triple mode of action, thus treating the disease and not just the symptoms.
Production & Manufacturing> OTC
Consumer Markets> Producers> Health & Beauty> Over-the-Counter Healthcare> Cough and Cold Preparations> Inhalers
Consumer Markets> Producers> Health & Beauty> Over-the-Counter Healthcare> Cough and Cold Preparations> Lozenges
Pharmaceuticals and Healthcare> Therapy Area> Ear Nose Throat Disorders> Rhinitis
Drug Research Drug Delivery Drug Discovery & Development
Contract Research & Services Clinical Trials Contract Research Contract Services
Automation IT & Software Laboratory Instrumentation
Inward Investment Packaging Regulatory Affairs